1. 1320 Eribulin mesylate in metastatic breast cancer, a focus on safety and efficacy in elderly patients. Results from the EVHALAVEN multicentric retrospective cohort. (September 2015) Authors: Martin-babau, J.; Robert, M.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Gourmelon, C.; Brunot, A.; Lefeuvre-plesse, C.; Korenbaum, C.; Petit, T.; Marquis, A.; Bourgeois, H.; Uwer, L.; Som, M.; Desclos, H.; Campone, M.; Campion, L.; Tredan, O.; Patsouris, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1865 Activity and toxicity profile of eribulin mesylate in heavily pretreated metastatic breast cancer: An observational study (EVHALAVEN). (September 2015) Authors: Patsouris, A.; Septans, A.L.; Paillard, M.J.; Pivot, X.; Soibinet, P.; Jovenin, N.; Robert, M.; Gourmelon, C.; Korembaum, C.; Petit, T.; Martin-babau, J.; Brunot, A.; Lefeuvre-plesse, C.; Adele, M.; Bourgeois, H.; Som, M.; Uwer, L.; Campone, M.; Campion, L.; Tredan, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 5B.02: LONGITUDINAL CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION IN A GENERAL POPULATION. (June 2015) Authors: Kuznetsova, T.; Thijs, L.; Knez, J.; Cauwenberghs, N.; Petit, T.; Gu, Y.M.; Zhang, Z.; Staessen, J.A. Journal: Journal of hypertension Issue: Volume 33(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. [OP.1B.01] VITAMIN K DEPENDENT PROTECTION OF RENAL FUNCTION IN MULTI-ETHNIC POPULATION STUDIES. (September 2016) Authors: WEI, F.; Drummen, N.E.A.; Schutte, A.E.; Thijs, L.; Jacobs, L.; Petit, T.; Yang, W.Y.; Smith, W.; Zhang, Z.Y.; Gu, Y.M.; Kuznetsova, T.; Verhamme, P.; Allegaert, K.; Schutte, R.; Lerut, E.; Evenepoel, P.; Vermeer, C.; Staessen, J.A. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. [OP.7C.07] DIASTOLIC LEFT VENTRICULAR FUNCTION IN RELATION TO COLLAGEN-SPECIFIC URINARY AND SERUM COLLAGEN BIOMARKERS IN A GENERAL POPULATION. (September 2016) Authors: Zhang, Z.; Ravassa, S.; Yang, W.Y.; Petit, T.; Petra, Z.; Lopez, B.; Wei, F.F.; Pontillo, C.; Thijs, L.; Jacobs, L.; Gonzalez, A.; Koeck, T.; Christian, D.; Voigt, J.U.; Verhamme, P.; Kuznetsova, T.; Diez, J.; Mischak, H.; Staessen, J.A. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. [PP.07.05] PLATELET ENDOTHELIAL AGGREGATION RECEPTOR 1 IS NOT A SUSCEPTIBILITY GENE FOR CARDIOVASCULAR DISEASE IN THE GENERAL POPULATION. (September 2016) Authors: Yang, W.; Petit, T.; Cauwenberghs, N.; Zhang, Z.; Thijs, L.; Salvi, E.; Izizi, B.; Vandenbriele, C.; Wei, F.; Gu, Y.; Jacobs, L.; Citterio, L.; Carpini, S. Delli; Barlassina, C.; Cusi, D.; Hoylaerts, M.F.; Verhamme, P.; Kuznetsova, T.; Staessen, J.A. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study. (24th February 2016) Authors: Trédan, O.; Follana, P.; Moullet, I.; Cropet, C.; Trager-Maury, S.; Dauba, J.; Lavau-Denes, S.; Diéras, V.; Béal-Ardisson, D.; Gouttebel, M.; Orfeuvre, H.; Stefani, L.; Jouannaud, C.; Bürki, F.; Petit, T.; Guardiola, E.; Becuwe, C.; Blot, E.; Pujade-Lauraine, E.; Bachelot, T. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Carboxylated nanodiamonds are neither cytotoxic nor genotoxic on liver, kidney, intestine and lung human cell lines. Issue 1 (August 2014) Authors: Paget, V.; Sergent, J. A.; Grall, R.; Altmeyer-Morel, S.; Girard, H. A.; Petit, T.; Gesset, C.; Mermoux, M.; Bergonzo, P.; Arnault, J. C.; Chevillard, S. Journal: Nanotoxicology Issue: Volume 8:Issue 1(2014:Feb.) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database. (February 2020) Authors: Gougis, P.; Carton, M.; Tchokothe, C.; Campone, M.; Dalenc, F.; Mailliez, A.; Levy, C.; Jacot, W.; Debled, M.; Leheurteur, M.; Bachelot, T.; Hennequin, A.; Perrin, C.; Gonçalves, A.; Uwer, L.; Eymard, J.C.; Petit, T.; Mouret-Reynier, M.A.; Chamorey, E.; Simon, G. Journal: Breast Issue: Volume 49(2020) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. (18th October 2016) Authors: Pierga, J.-Y.; Bidard, F.-C.; Autret, A.; Petit, T.; Andre, F.; Dalenc, F.; Levy, C.; Ferrero, J.-M.; Romieu, G.; Bonneterre, J.; Lerebours, F.; Bachelot, T.; Kerbrat, P.; Campone, M.; Eymard, J.-C.; Mouret-Reynier, M.-A.; Gligorov, J.; Hardy-Bessard, A.-C.; Lortholary, A.; Soulie, P. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗